The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Validation of Toxicogenomic Technologies: A Workshop Summary
Following a judicial clerkship at the U.S. Court of Appeals for the Federal Circuit, Dr. Sung was in private practice specializing in biotechnology patent litigation with several international law firms. He received a Ph.D. in microbiology from the U.S. Department of Defense, Uniformed Services University and a J.D. from American University, Washington College of Law. In addition to numerous articles, Dr. Sung is the author of two books: Patent Law Handbook and Patent Infringement Remedies.
Russell D. Wolfinger is director of scientific discovery and genomics at SAS Institute, Inc, one of the top 10 software companies in the world. He earned a Ph.D. in statistics from North Carolina State in 1989 and has been at SAS ever since. His first 10 years were devoted to developing statistical procedures in the areas of linear and nonlinear mixed models, multiple testing, and density estimation. In 2000, he started the Scientific Discovery department at SAS and since then has been leading a team in research and development of software solutions in the areas of genetics, transcriptomics, and proteomics/metabalomics. Dr. Wolfinger is an adjunct faculty member at North Carolina State University, University of North Carolina at Chapel Hill, and University of Missouri.